Acid-Active Cell-Penetrating Peptides for in Vivo Tumor-Targeted Drug Delivery

被引:297
|
作者
Jin, Erlei [3 ]
Zhang, Bo [3 ]
Sun, Xuanrong [1 ,2 ]
Zhou, Zhuxian [3 ]
Ma, Xinpeng [3 ]
Sun, Qihang [3 ]
Tang, Jianbin [1 ,2 ]
Shen, Youqing [1 ,2 ]
Van Kirk, Edward [4 ]
Murdoch, William J. [4 ]
Radosz, Maciej [3 ]
机构
[1] Zhejiang Univ, Ctr Bionanoengn, Hangzhou 310027, Peoples R China
[2] Zhejiang Univ, Dept Chem & Biol Engn, State Key Lab Chem Engn, Hangzhou 310027, Peoples R China
[3] Univ Wyoming, Dept Chem & Petr Engn, Laramie, WY 82071 USA
[4] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA
基金
中国国家自然科学基金;
关键词
PROTEIN; CANCER; TRANSDUCTION; NANOCARRIER; TRANSPORT; MICELLE; PROBES; RNA; PH;
D O I
10.1021/ja311180x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cell-penetrating peptides (CPPs) such as transactivator of transcription (TAT) peptide have long been explored for promoting in vitro cell penetration and nuclear targeting of various cargos, but their positive charges cause strong nonspecific interactions, making them inapplicable for many in vivo applications. In this work, we used TAT to demonstrate a molecular modification approach for inhibiting nonspecific interactions of CPPs in the bloodstream while reactivating their functions in the targeted tissues or cells. The TAT lysine residues' amines were amidized to succinyl amides ((a)TAT), completely inhibiting TAT's nonspecific interactions in the blood compartment; once in the acidic tumor interstitium or internalized into cell endo/lysosomes, the succinyl amides in the (a)TAT were quickly hydrolyzed, fully restoring TAT's functions. Thus, (a)TAT-functionalized poly(ethylene glycol)-block-poly(epsilon-caprolactone) micelles achieved long circulation in the blood compartment and efficiently accumulated and delivered doxorubicin to tumor tissues, giving rise to high antitumor activity and low cardiotoxicity. This amidization strategy effectively and easily enables in vivo applications of CPPs.
引用
收藏
页码:933 / 940
页数:8
相关论文
共 50 条
  • [1] Cell-Penetrating Peptides: A Powerful Tool for Targeted Drug Delivery
    Kotadiya, Dushyant D.
    Patel, Piyushkumar
    Patel, Hitesh D.
    CURRENT DRUG DELIVERY, 2023, 21 (03) : 368 - 388
  • [2] Cell-penetrating Peptides and Drug Delivery
    Huang, Yongzhuo
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2014, 15 (03) : 191 - 191
  • [3] Design of new acid-activated cell-penetrating peptides for tumor drug delivery
    Yao, Jia
    Ma, Yinyun
    Zhang, Wei
    Li, Li
    Zhang, Yun
    Zhang, Li
    Liu, Hui
    Ni, Jingman
    Wang, Rui
    PEERJ, 2017, 5
  • [4] Cell-Penetrating Peptides: Possibilities and Challenges for Drug Delivery in Vitro and in Vivo
    Skotland, Tore
    Iversen, Tore Geir
    Torgersen, Maria Lyngaas
    Sandvig, Kirsten
    MOLECULES, 2015, 20 (07) : 13313 - 13323
  • [5] Tumor selective delivery by cell-penetrating peptides
    Mae, Maarja
    Myrberg, Helena
    Langel, Uelo
    Lindgren, Maria
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 188 - 188
  • [6] The use of cell-penetrating peptides for drug delivery
    Temsamani, J
    Vidal, P
    DRUG DISCOVERY TODAY, 2004, 9 (23) : 1012 - 1019
  • [7] Cell-penetrating peptides, electroporation and drug delivery
    Cahill, K.
    IET SYSTEMS BIOLOGY, 2010, 4 (06) : 367 - 378
  • [8] Progress in tumour-targeted drug delivery based on cell-penetrating peptides
    Kong, Xinru
    Xu, Jiangkang
    Yang, Xiaoye
    Zhai, Yujia
    Ji, Jianbo
    Zhai, Guangxi
    JOURNAL OF DRUG TARGETING, 2022, 30 (01) : 46 - 60
  • [9] Nucleic acid delivery by cell-penetrating peptides
    Langel, Ulo
    PROCEEDINGS OF THE ESTONIAN ACADEMY OF SCIENCES, 2023, 72 (04) : 361 - 370
  • [10] Drug Nanocrystals for Active Tumor-Targeted Drug Delivery
    Lu, Linwei
    Xu, Qianzhu
    Wang, Jun
    Wu, Sunyi
    Luo, Zimiao
    Lu, Weiyue
    PHARMACEUTICS, 2022, 14 (04)